Molecularly targeted therapy for Leukemia: MLL-fusion/MYC/LIN-28 suppresses the expression of tumor suppressor p53 homologue TAp73 via blockade of its target miRNA, 11/August/2014, 22.09

Molecularly targeted therapy for Leukemia: MLL-fusion/MYC/LIN-28 suppresses the expression of tumor suppressor p53 homologue TAp73 via blockade of its target miRNA, 11/August/2014, 22.09

Molecularly targeted therapy for Leukemia: MLL-fusion/MYC/LIN-28 suppresses the expression of tumor suppressor p53 homologue TAp73 via blockade of its target miRNA, 11/August/2014, 22.09 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Molecularly targeted therapy for Leukemia: MLL-fusion/MYC/LIN-28 suppresses the expression of tumor suppressor p53 homologue TAp73 via blockade of its target miRNA, 11/August/2014,  22.09Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org